DUX4L9: A Potential Drug Target and Biomarker for Various Diseases

Target Name: DUX4L9

NCBI ID: G554045

DUX4L9

DUX4L9: A Potential Drug Target and Biomarker for Various Diseases

Double homeobox protein 4C (DUX4L9) is a protein that has been identified as a potential drug target or biomarker for various diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. DUX4L9 is a transmembrane protein that is expressed in a variety of tissues, including the brain, pancreas, and muscle. It plays a role in the development and maintenance of tissues, including the nervous system and endocrine system.

DUX4L9 and its function

DUX4L9 is a member of the homeobox gene family, which is a family of transcription factors that are involved in the development and maintenance of tissues. The homeobox genes encode for a variety of proteins that play important roles in the development and maintenance of tissues, including the nervous system and endocrine system.

DUX4L9 is a 21-kDa protein that is expressed in a variety of tissues, including the brain, pancreas, and muscle. It is highly conserved, with a calculated pI of 6.5 and a predicted localization in the cytoplasm of cells. DUX4L9 is associated with the development and maintenance of tissues, including the nervous system and endocrine system.

DUX4L9 and cancer

DUX4L9 has been identified as a potential drug target or biomarker for cancer. Several studies have shown that DUX4L9 is highly expressed in a variety of cancer types, including lung cancer, breast cancer, and colon cancer. Additionally, studies have shown that DUX4L9 is involved in the development and progression of cancer, including the regulation of cell growth, apoptosis, and angiogenesis.

DUX4L9 and neurodegenerative diseases

DUX4L9 has also been identified as a potential drug target or biomarker for neurodegenerative diseases. Neurodegenerative diseases, including Alzheimer's disease, Parkinson's disease, and Huntington's disease, are characterized by the progressive loss of brain cells and the development of neurofibrillary tangles and neuroglial cells. Several studies have shown that DUX4L9 is involved in the development and progression of neurodegenerative diseases, including the regulation of neurotransmitter signaling, inflammation, and cellular stress.

DUX4L9 and autoimmune disorders

DUX4L9 has also been identified as a potential drug target or biomarker for autoimmune disorders. Autoimmune disorders, including rheumatoid arthritis, lupus, and multiple sclerosis, are characterized by the immune system attacking the body's own tissues. Several studies have shown that DUX4L9 is involved in the development and progression of autoimmune disorders, including the regulation of immune cell function and the development of autoantibodies.

DUX4L9 as a drug target

DUX4L9 has been identified as a potential drug target for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Studies have shown that DUX4L9 can be targeted with small molecules, including inhibitors of tyrosine kinase activity, which can lead to the inhibition of cell proliferation and the regulation of signaling pathways. Additionally, DUX4L9 has been shown to play a role in the regulation of cellular stress, including the regulation of inflammation and cellular apoptosis.

DUX4L9 as a biomarker

DUX4L9 has also been identified as a potential biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Studies have shown that DUX4L9 can be used as a biomarker for disease progression, including the detection of disease-specific protein levels in patient samples. Additionally, DUX4L9 has been shown to play a role in the regulation of cellular stress, including the regulation of inflammation and cellular apoptosis, which can be used as a biomarker for disease severity.

Conclusion

DUX4L9 is a protein that has been identified as a potential drug target or biomarker for a variety of diseases, including cancer, neurodegenerative diseases, and autoimmune disorders. Its function is involved in the development and maintenance of tissues, including the nervous system and endocrine system. Studies have shown that DUX4L9 is highly expressed in a variety of cancer types and is involved in the development and progression of cancer, as

Protein Name: Double Homeobox 4 Like 9

The "DUX4L9 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about DUX4L9 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets